** Shares of medtech firm Senseonics Holdings SENS.A down a penny post-market to 54 cents as it looks to raise equity
** Germantown, Maryland-based maker of continuous glucose monitoring (CGM) systems commences $50 mln public offering
** Co says Abbott Laboratories ABT.N agreed to buy up to $25 mln of shares in concurrent private placement
** It intends to use net proceeds from both transactions to fund ongoing launch of Eversense 365, and continued development of its pipeline
** TD Cowen and Barclays are jt-lead bookrunners for proposed offering, joined by RBC and Lake Street
** Senseonics has ~654.3 mln shares outstanding and ~585.1 mln shares of free float, per LSEG data
** SENS fell for 5th straight day on Thurs. Stock well off its 52-week high of $1.40 hit in mid-Feb
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。